Stem cell transplant in the treatment of childhood biphenotypic acute leukemia

Pediatric Blood and Cancer

Volumn 53, Issue 3, 2009, Pages 444-452

  Park, Jeong A ^a   Ghim, Thad T ^a   Keun, Wook Bae ^a   Ho, Joon Im ^a   Seong, Soo Jang ^a   Chan, Jeong Park ^a   Hyun, Sook Chi ^a   Jong, Jin Seo ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Biphenotypic acute leukemia; High hyperdiploidy; Immunophenotype; MLL rearrangement; Philadelphia chromosome

Indexed keywords

ASPARAGINASE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; IDARUBICIN; IMATINIB; PREDNISOLONE; VINCRISTINE;

ACUTE BIPHENOTYPIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CHILD; CHILDHOOD LEUKEMIA; CHROMOSOME; CLINICAL ARTICLE; CYTOGENETICS; DIPLOIDY; EVENT FREE SURVIVAL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; HYPERDIPLOIDY; IMMUNOPHENOTYPING; INFANT; MALE; MEDICAL RECORD REVIEW; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SCHOOL CHILD; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; LEUKEMIA, BIPHENOTYPIC, ACUTE; MALE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 67651236074     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22105     Document Type: Article

References (39)

1. Bene MC, Castoldi G, Knapp W, et al. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia 1995;9:1783-1786.
2. Carbonell F, Swansbury J, Min T, et al. Cytogenetic findings in acute biphenotypic leukaemia. Leukemia 1996;10:1283-1287. (Pubitemid 26261423)
3. Legrand O, Perrot JY, Simonin G, et al. Adult biphenotypic acute leukaemia: An entity with poor prognosis which is related to unfavourable cytogenetics and P-glycoprotein over-expression. Br J Haematol 1998;100:147-155. (Pubitemid 28051853)
4. Owaidah TM, Al Beihany A, Iqbal MA, et al. Cytogenetics, molecular and ultrastructural characteristics of biphenotypic acute leukemia identified by the EGIL scoring system. Leukemia 2006; 20:620-626.
5. Mirro J, Zipf TF, Pui CH, et al. Acute mixed lineage leukemia: Clinicopathologic correlations and prognostic significance. Blood 1985;66:1115-1123. (Pubitemid 16250277)
6. Rubio MT, Dhedin N, Boucheix C, et al. Adult T-biphenotypic acute leukaemia: Clinical and biological features and outcome. Br J Haematol 2003;123:842-849. (Pubitemid 37533296)
7. Fleming DR, Doukas MA, Jennings DC, et al. Diagnostic and clinical implications of lineage fidelity in acute leukemia patients undergoing allogeneic stem cell transplantation. Leuk Lymphoma 2000;36:309-313. (Pubitemid 30060181)
8. Johny A, SongKW, Nantel SH, et al. Early stem cell transplantation for refractory acute leukemia after salvage therapy with high-dose etoposide and cyclophosphamide. Biol Blood Marrow Transplant 2006;12:480-489.
9. Pui CH, Rubnitz JE, Hancock ML, et al. Reappraisal of the clinical and biologic significance of myeloid-associated antigen expression in childhood acute lymphoblastic leukemia. J Clin Oncol 1998;16: 3768-3773. (Pubitemid 29001528)
10. Williams DL, Harris A, Williams KJ, et al. A direct bone marrow chromosome technique for acute lymphoblastic leukemia. Cancer Genet Cytogenet 1984;13:239-257. (Pubitemid 15216347)
11. Shaffer LG, Tommerup N. ISCN 2005: An international system for human cytogenetic nomenclature. Basal, Switzerland: Karger; 2005.
12. Cheson BD, Bennett JM, Kopecky KJ, et al. Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. J Clin Oncol 2003;21:4642-4649.
13. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
14. Bennett JM, Catovsky D, Daniel MT, et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med 1985;103:620-625.
15. Gaynon PS, Steinherz PG, Bleyer WA, et al. Intensive therapy for children with acute lymphoblastic leukaemia and unfavourable presenting features. Early conclusions of study CCG-106 by the Childrens Cancer Study Group. Lancet 1988;2:921-924.
16. Reaman GH, Sposto R, Sensel MG, et al. Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group. J Clin Oncol 1999;17:445-455. (Pubitemid 29075227)
17. Uckun FM, Nachman JB, Sather HN, et al. Poor treatment outcome of Philadelphia chromosome-positive pediatric acute lymphoblastic leukemia despite intensive chemotherapy. Leuk Lymphoma 1999;33:101-106.
18. Hutchinson RJ, Gaynon PS, Sather H, et al. Intensification of therapy for children with lower-risk acute lymphoblastic leukemia: Long-term follow-up of patients treated on Children's Cancer Group Trial 1881. J Clin Oncol 2003;21:1790-1797.
19. Heath JA, Steinherz PG, Altman A, et al. Human granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia: A Children's Cancer Group Study. J Clin Oncol 2003;21:1612-1617. (Pubitemid 46594116)
20. Hilden JM, Dinndorf PA, Meerbaum SO, et al. Analysis of prognostic factors of acute lymphoblastic leukemia in infants: Report on CCG 1953 from the Children's Oncology Group. Blood 2006;108:441-451.
21. Seibel NL, Steinherz PG, Sather HN, et al. Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: A report from the Children's Oncology Group. Blood 2008;111:2548-2555.
22. Bell BA, Brockway GN, Shuster JJ, et al. A comparison of red blood cell thiopurine metabolites in children with acute lymphoblastic leukemia who received oral mercaptopurine twice daily or once daily: A Pediatric Oncology Group study (now The Children's Oncology Group). Pediatr Blood Cancer 2004;43:105-109.
23. Lee JH, Min YH, Chung CW, et al. Prognostic implications of the immunophenotype in biphenotypic acute leukemia. Leuk Lymphoma 2008;49:700-709.
24. Killick S, Matutes E, Powles RL, et al. Outcome of biphenotypic acute leukemia. Haematologica 1999;84:699-706.
25. Weir EG, Ali Ansari-Lari M, Batista DA, et al. Acute bilineal leukemia: A rare disease with poor outcome. Leukemia 2007;21:2264-2270. (Pubitemid 350011698)
26. He G, Wu D, Sun A, et al. B-Lymphoid and myeloid lineages biphenotypic acute leukemia with t(8;21)(q22;q22). Int J Hematol 2008;87:132-136.
27. Pui CH, Evans WE. Acute lymphoblastic leukemia. N Engl J Med 1998;339:605-615.
28. Cline MJ. The molecular basis of leukemia. N Engl J Med 1994;330:328-336.
29. BleyerWA, Poplack DG. Prophylaxis and treatment of leukemia in the central nervous system and other sanctuaries. Semin Oncol 1985;12:131-148. (Pubitemid 15065137)
30. Kobayashi R, Tawa A, Hanada R, et al. Extramedullary infiltration at diagnosis and prognosis in children with acute myelogenous leukemia. Pediatr Blood Cancer 2007;48:393-398. (Pubitemid 46340103)
31. World Health Organization. WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edition. Lyon, France: International Agency for Research on Cancer; 2008.
32. Ball ED, Davis RB, Griffin JD, et al. Prognostic value of lymphocyte surface markers in acute myeloid leukemia. Blood 1991;77:2242-2250.
33. Cross AH, Goorha RM, Nuss R, et al. Acute myeloid leukemia with T-lymphoid features: A distinct biologic and clinical entity. Blood 1988;72:579-587. (Pubitemid 18226265)
34. Kita K, Miwa H, Nakase K, et al., Clinical importance of CD7 expression in acute myelocytic leukemia. The Japan Cooperative Group of Leukemia/Lymphoma. Blood 1993;81:2399-2405.
35. Miller DR, Leikin S, Albo V, et al. Use of prognostic factors in improving the design and efficiency of clinical trials in childhood leukemia: Children's Cancer Study Group Report. Cancer Treat Rep 1980;64:381-392.
36. Kaspers GJ, Smets LA, Pieters R, et al. Favorable prognosis of hyperdiploid common acute lymphoblastic leukemia may be explained by sensitivity to antimetabolites and other drugs: Results of an in vitro study. Blood 1995;85:751-756.
37. Ito C, Kumagai M, Manabe A, et al. Hyperdiploid acute lymphoblastic leukemia with 51 to 65 chromosomes: A distinct biological entity with a marked propensity to undergo apoptosis. Blood 1999;93:315-320. (Pubitemid 29019418)
38. Heerema NA, Sather HN, Sensel MG, et al. Prognostic impact of trisomies of chromosomes 10,17 and 5 among children with acute lymphoblastic leukemia and high hyperdiploidy (>50 chromosomes). J Clin Oncol 2000;18:1876-1887.
39. Yanada M, Naoe T. Imatinib combined chemotherapy for Philadelphia chromosome-positive acute lymphoblastic leukemia: Major challenges in current practice. Leuk Lymphoma 2006;47: 1747-1753. (Pubitemid 44649756)